Press Release Archive

01.25.2009

Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company

01.16.2009

Pfizer Receives FDA Complete Response Letter for Lasofoxifene

01.13.2009

Stephen W. Sanger Elected to Pfizer’s Board of Directors

01.06.2009

U.S. Patent and Trademark Office Accepts Pfizer’s Reissue Application on Lipitor Enantiomer Patent

12.21.2008

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

12.21.2008

Bradley E. Lerman Joins Pfizer as Senior Vice President of Litigation

12.15.2008

Pfizer Declares a 32-Cent First-Quarter 2009 Dividend

12.14.2008

Pfizer Invites Public to View and Listen to Webcast of January 28 Conference Call with Analysts

12.11.2008

Pfizer Announces Results from Trial of AROMASIN in Postmenopausal Women with Hormone Sensitive Early Breast Cancer

12.08.2008

Pfizer and Sigma-Tau Announce an Agreement to Market a Potential New Treatment for Malaria in Africa

12.02.2008

Patients Taking Lipitor Had a Significantly Reduced Risk of Cardiovascular Events Compared with Patients Taking Simvastatin, New Observational Study Shows

11.25.2008

Pfizer’s Novel HIV/AIDS Treatment SELZENTRY™ Becomes the Latest Fully Approved Antiretrovial for Treatment-Experienced HIV Patients